Greyson International, Inc. ShopNBC Appearance Time Change
Greyson to Now Appear in Prime Time on Wednesday, March 10, at 7 p.m. EST
BOCA RATON, Fla.—March 8, 2010 — Greyson International, Inc. (GYSN.PK) announced today its upcoming ShopNBC appearance has been moved to prime time. Veteran television personality and Greyson International CEO Harvey Tauman will appear as the spokesperson on behalf of the Company to feature the Company’s new Trilexon® products on air on Wednesday, March 10, 2010 at approximately 7 p.m. EST during the “ShopBeauty” hour.
Tauman will discuss the benefits of its first three products featuring Trilexon®, a new delivery system designed by Greyson that helps to improve the effectiveness of topical applications. Trilexon® Restorative Night Créme, Trilexon® Revitalizing Eye Créme and Trilexon® Fast-Acting Line Erasure are the first skincare products to utilize the unique delivery system, which precisely delivers key ingredients to the appropriate areas through “messengers”.
ShopNBC is a national television shopping network that reaches 75 million homes in the United States via cable affiliates and satellite, including DISH Network channels 134 and 228 and DIRECTV channel 316. ShopNBC is also broadcast live on the Web at www.ShopNBC.TV 24 hours per day.
“We are looking forward to appearing in prime time on ShopNBC,” said Greyson International CEO Harvey Tauman. “This evening time slot will allow us to reach a larger audience. We are pleased to offer our new Trilexon® products, and showcase how this new skincare technology provides remarkable results.”
Tauman is a nationally recognized spokesperson, and has made numerous appearances on national television shopping networks. His accomplishments include achieving sales of $2.7 million in one day, breaking a record for most single-day sales of personal care products on a television shopping network.
Tauman works closely with Greyson International Head of Research and Development Charles Fox, a world-renowned chemist, and the former Director of Product Development for the Personal Products Division of Warner-Lambert Company, now owned by Pfizer (NYSE: PFE), as well as the former Principal Research Chemist for Lever Brothers Company. Fox has several patents to his name and has contributed to numerous industry publications as an expert chemist. After years of research, Fox, Tauman and Chaudhury Mukesh Prasad, a business partner of Tauman’s for 38 years, discovered Trilexon®. The group believes it can revolutionize the way topical applications work, positively affecting the skincare, beauty, pharmaceutical and pain management industries, to name a few.
Greyson International has received confirmation that Trilexon® is safe for use based on thorough safety testing on an independent panel of participants. The independent study on Trilexon® was performed by Dr. Peter Pugliese, a world-renowned physician who has spent over 25 years studying specializing in aging mechanisms of human skin. Dr. Pugliese holds several patents, has published hundreds of articles and has lectured on every continent. He was awarded the Maison De Navarre Award for his contributions to cosmetic science.
Trilexon® has received trademark approval and is patent pending. All Greyson products are manufactured in the U.S. The Company does not test its products on animals.
About Greyson International, Inc.
Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Greyson has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of virtually every topical application in today’s cosmetic market and every over-the-counter topical drug application. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonproducts.com, join the Greyson Facebook group page by visiting www.facebook.com and searching “Greyson Products” or follow Greyson on Twitter at www.twitter.com/greysonproducts.
This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.